Statistics
Publications
12
Citations
591
H-Index
12
Active since
2014
Shihong Peng is an author at East China Normal University specializing in pharmacology, medicine, and oncology.
Publications per year
2014–2021
12
12
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Weiqiang Lü, Weiwei Yu, Jiacheng He et al. · EMBO Molecular Medicine · 2020 · 111 citations · Full text
Medicine, Immunology, Oncology +17
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Yundong He, Shihong Peng, Jinhua Wang et al. · Nature Communications · 2016 · 110 citations · Full text
Medicine, Oncology, Pharmacology +15
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Chen Huang, Aiwu Bian, Lian-Fang Yang et al. · Oncogene · 2021 · 78 citations · Full text
Medicine, Oncology, Pharmacology +16
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
Meichun Hu, Shihong Peng, Yundong He et al. · Oncotarget · 2015 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12